Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy

Osteoporosis International

Volumn 5, Issue 4, 1995, Pages 276-280

  Riis, B J ^a   Overgaard, K ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Bone loss; Bone markers; Treatment follow up

Indexed keywords

BIOCHEMICAL MARKER; ESTROGEN; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; FEMALE; FOREARM; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; PATIENT MONITORING; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SPINE; URINALYSIS;

BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; MIDDLE AGE; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES;

EID: 0029080888     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/BF01774018     Document Type: Article

References (29)

1. Dose-response evaluation of cyclic estrogen/gestagen in postmeno-pausal women: placebo-controlled trial of its gynecologic and metabolic actions
2. The minimum effective dose of estrogen for prevention of postmenopausal bone loss
3. En recherche de la difference (p<0.05)
4. Early menopausal changes in bone mass and sex steroids
5. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss
6. Cyproterone acetate, and alternative gestagen in postmenopausal oestrogen/gestagen therapy
7. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects of bone, calcium and lipid metabolism, climacteric symptoms, and bleeding
8. Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding
9. Bone mass measured by photon absorptiometry: comparison of forearm, heel and spine
10. Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry
11. Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density on the lumbar spine
12. A radioimmunoassay for bone Gla protein (BGP) in human plasma
13. An easy and reliable method for determination of urinary hydroxyproline
14. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study
15. The risk of breast cancer after estrogen and estrogen-progestin replacement
16. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss. Do they exist?
17. Prediction of rapid bone loss in postmenopausal women
18. Screening procedure for women at risk of developing postmenopausal osteoporosis
19. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study
20. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women
21. Effect of salcatonin given intranasally on early postmenopausal bone loss
22. Intranasal salmon calcitonin for prevention of postmenopausal bone loss: a placebo-controlled study in 109 women
23. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
24. Effect of intermittent cyclical therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
25. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
26. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
27. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links
28. Immunoassay for urinary pyridinoline: the new marker of bone resorption
29. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine